Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

INSYS Therapeutics Inc (NASDAQ:INSY)

15.95
Delayed Data
As of Jul 22
 +0.33 / +2.11%
Today’s Change
11.45
Today|||52-Week Range
46.17
-44.29%
Year-to-Date
Huge Drugmaker Fines for Bribing Healthcare Providers
Jul 22 / MotleyFool.com - Paid Partner Content
How Do Healthcare Companies Market Their Products?
Jul 19 / MotleyFool.com - Paid Partner Content
This Marijuana Drugmaker Sets Its Sights on a 9-Figure Market
Jul 20 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close15.62
Today’s open15.78
Day’s range15.60 - 16.32
Volume592,893
Average volume (3 months)740,652
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)+48.08%
Earnings growth (this year)-77.97%
Earnings growth (next 5 years)+28.00%
Revenue growth (last year)+48.92%
P/E ratio23.1
Price/Sales6.55
Price/Book4.52

Competitors

 Today’s
change
Today’s
% change
PBYIPuma Biotechnology I...+7.00+20.28%
DERMDermira Inc-0.29-0.91%
LCILannett Company Inc-0.11-0.36%
SRPTSarepta Therapeutics...+1.24+5.47%
Data as of 4:01pm ET, 07/22/2016

Financials

Next reporting dateAugust 9, 2016
EPS forecast (this quarter)$0.06
Annual revenue (last year)$330.8M
Annual profit (last year)$58.5M
Net profit margin17.68%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
John N. Kapoor
Chief Operating Officer &
Executive Vice President
Daniel Brennan
Corporate headquarters
Chandler, Arizona

Forecasts

Partner Offers

Search for Jobs